Selective Decrease in Allodynia With High‐Frequency Neuromodulation via High‐Electrode‐Count Intrafascicular Peripheral Nerve Interface After Brachial Plexus Injury
Objectives Kilohertz high‐frequency alternating current (KHFAC) electrical nerve stimulation produces a reversible nerve block in peripheral nerves in human patients with chronic pain pathologies. Although this stimulation methodology has been verified with nonselective extrafascicular electrodes, t...
Saved in:
Published in | Neuromodulation (Malden, Mass.) Vol. 22; no. 5; pp. 597 - 606 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Limited
01.07.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objectives
Kilohertz high‐frequency alternating current (KHFAC) electrical nerve stimulation produces a reversible nerve block in peripheral nerves in human patients with chronic pain pathologies. Although this stimulation methodology has been verified with nonselective extrafascicular electrodes, the effectiveness of producing a selective nerve block with more‐selective intrafascicular electrodes has not been well documented. The objective of this study was to examine whether intrafascicular electrodes can block painful stimuli while preserving conduction of other neural activity within the implanted nerve.
Materials and Methods
We analyzed the effects of various stimulation waveforms delivered through Utah Slanted Electrode Arrays (USEAs) implanted in the median nerve of a male human subject with a left brachial plexus injury. We compared KHFAC stimulation with a sham control.
Results
KHFAC stimulation through USEA electrodes produced a reduction in pain sensitivity in the palmar aspect of the left middle finger. KHFAC had limited effects on the patient's ability to feel tactile probing in the same area or move the digits of his left hand. Other tested stimulation parameters either increased or showed no reduction in pain.
Conclusions
KHFAC stimulation in peripheral nerves through intrafascicular electrodes demonstrated a selective reduction in pain sensitivity while preserving other nerve functions. This treatment may benefit patient populations who have chronic pain originating from peripheral nerves, but who do not want to block whole‐nerve function in order to preserve sensory and motor function reliant on the implanted nerve. Furthermore, KHFAC may benefit patients who respond negatively to other forms of peripheral nerve stimulation therapy. |
---|---|
Bibliography: | Source(s) of financial support: National Science Foundation Award No. BCS‐1533649. For more information on author guidelines, an explanation of our peer review process, and conflict of interest informed consent policies, please go to www.wiley.com/WileyCDA/Section/id-301854.html Conflict of Interest Dr. Clark and Dr. Warren hold US patents on the electrode arrays and the methods for protecting the electrodes from electrical noise that were used in this study (US Patent Nos. 8,359,083, 8,639,312, and 8,855,737). Dr. Clark, Dr. Hutchinson, Dr. Page, and Mr. Kluger are inventors of the implant carrier device used during surgery (patent pending, International Application No. PCT/US2017/044427). Dr. Clark, Dr. Davis, Dr. Duncan, Dr. Page, and Mr. Kluger are inventors of using implantable electrode arrays to block transmission of neural signals in subpopulations of peripheral nerve fibers within a peripheral nerve (patent pending, U.S. Application No. 15/583,568). ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 1094-7159 1525-1403 |
DOI: | 10.1111/ner.12802 |